Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1960 1
1965 1
1979 1
1980 3
1981 4
1982 3
1983 4
1984 1
1985 7
1986 3
1987 9
1988 8
1989 9
1990 11
1991 15
1992 13
1993 22
1994 11
1995 26
1996 23
1997 34
1998 46
1999 37
2000 31
2001 54
2002 66
2003 81
2004 99
2005 135
2006 182
2007 208
2008 216
2009 241
2010 326
2011 397
2012 509
2013 587
2014 672
2015 752
2016 804
2017 836
2018 1020
2019 1164
2020 1355
2021 1740
2022 2071
2023 1997
2024 940

Text availability

Article attribute

Article type

Publication date

Search Results

14,940 results

Results by year

Filters applied: . Clear all
Page 1
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y; CAPSTONE-1 Study Group. Wang J, et al. Among authors: fang y. Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13. Lancet Oncol. 2022. PMID: 35576956 Clinical Trial.
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion.
Deng S, Zhang Y, Wang H, Liang W, Xie L, Li N, Fang Y, Wang Y, Liu J, Chi H, Sun Y, Ye R, Shan L, Shi J, Shen Z, Wang Y, Wang S, Brosseau JP, Wang F, Liu G, Quan Y, Xu J. Deng S, et al. Among authors: fang y. Cell. 2024 Apr 25;187(9):2305-2323.e33. doi: 10.1016/j.cell.2024.03.019. Epub 2024 Apr 12. Cell. 2024. PMID: 38614099
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Lin CC, Chang TC, Wang Y, Guo L, Gao Y, Bikorimana E, Lemoff A, Fang YV, Zhang H, Zhang Y, Ye D, Soria-Bretones I, Servetto A, Lee KM, Luo X, Otto JJ, Akamatsu H, Napolitano F, Mani R, Cescon DW, Xu L, Xie Y, Mendell JT, Hanker AB, Arteaga CL. Lin CC, et al. Among authors: fang yv. Nat Commun. 2024 Mar 13;15(1):2287. doi: 10.1038/s41467-024-46495-2. Nat Commun. 2024. PMID: 38480701 Free PMC article.
Targeting neutrophils: Mechanism and advances in cancer therapy.
Yang S, Jia J, Wang F, Wang Y, Fang Y, Yang Y, Zhou Q, Yuan W, Bian Z. Yang S, et al. Among authors: fang y. Clin Transl Med. 2024 Mar;14(3):e1599. doi: 10.1002/ctm2.1599. Clin Transl Med. 2024. PMID: 38450975 Free PMC article. Review.
Cancer immunotherapy efficacy and machine learning.
Fang Y, Chen X, Cao C. Fang Y, et al. Expert Rev Anticancer Ther. 2024 Jan-Feb;24(1-2):21-28. doi: 10.1080/14737140.2024.2311684. Epub 2024 Feb 12. Expert Rev Anticancer Ther. 2024. PMID: 38288663 Review.
Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors.
Xu C, Wang Q, Wang D, Wang W, Fang W, Li Z, Liu A, Yu J, Zhong W, Wang Z, Zhang Y, Liu J, Zhang S, Cai X, Liu A, Li W, Zhan P, Liu H, Lv T, Miao L, Min L, Chen Y, Yuan J, Wang F, Jiang Z, Lin G, Huang L, Pu X, Lin R, Liu W, Rao C, Lv D, Yu Z, Li X, Tang C, Zhou C, Zhang J, Xue J, Guo H, Chu Q, Meng R, Wu J, Zhang R, Zhou J, Zhu Z, Li Y, Qiu H, Xia F, Lu Y, Chen X, Ge R, Dai E, Han Y, Pan W, Pang F, He Q, Huang J, Wang K, Wu F, Xu B, Wang L, Zhu Y, Lin L, Xie Y, Lin X, Cai J, Xu L, Li J, Jiao X, Li K, Wei J, Feng H, Wang L, Du Y, Yao W, Shi X, Niu X, Yuan D, Yao Y, Huang J, Feng Y, Zhang Y, Sun P, Wang H, Ye M, Wang Z, Hao Y, Wang Z, Wan B, Lv D, Yang S, Kang J, Zhang J, Zhang C, Ou J, Shi L, Wang Y, Li B, Zhang Z, Li Z, Liu Z, Yang N, Wu L, Wang H, Jin G, Wang G, Wang J, Fang M, Fang Y, Li Y, Wang X, Zhang Y, Zhu X, Shen Y, Ma S, Wang B, Si L, Song Y, Lu Y, Chen J, Song Z. Xu C, et al. Among authors: fang y. Glob Med Genet. 2024 Feb 27;11(1):86-99. doi: 10.1055/s-0044-1781457. eCollection 2024 Jan. Glob Med Genet. 2024. PMID: 38414979 Free PMC article. Review.
Source-free unsupervised domain adaptation: A survey.
Fang Y, Yap PT, Lin W, Zhu H, Liu M. Fang Y, et al. Neural Netw. 2024 Jun;174:106230. doi: 10.1016/j.neunet.2024.106230. Epub 2024 Mar 11. Neural Netw. 2024. PMID: 38490115 Review.
FUS reads histone H3K36me3 to regulate alternative polyadenylation.
Jia J, Fan H, Wan X, Fang Y, Li Z, Tang Y, Zhang Y, Huang J, Fang D. Jia J, et al. Among authors: fang y. Nucleic Acids Res. 2024 Mar 18:gkae184. doi: 10.1093/nar/gkae184. Online ahead of print. Nucleic Acids Res. 2024. PMID: 38499486
14,940 results
You have reached the last available page of results. Please see the User Guide for more information.